ClariVest Asset Management’s Sage Therapeutics SAGE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-14,078
| Closed | -$662K | – | 835 |
|
|
2023
Q2 | $662K | Sell |
14,078
-2,797
| -17% | -$132K | 0.03% | 316 |
|
|
2023
Q1 | $708K | Sell |
16,875
-16
| -0.1% | -$671 | 0.03% | 332 |
|
|
2022
Q4 | $644K | Sell |
16,891
-65
| -0.4% | -$2.48K | 0.03% | 351 |
|
|
2022
Q3 | $664K | Sell |
16,956
-5,344
| -24% | -$209K | 0.03% | 319 |
|
|
2022
Q2 | $720K | Sell |
22,300
-5,800
| -21% | -$187K | 0.03% | 328 |
|
|
2022
Q1 | $930K | Hold |
28,100
| – | – | 0.04% | 293 |
|
|
2021
Q4 | $1.2M | Sell |
28,100
-2,800
| -9% | -$119K | 0.04% | 295 |
|
|
2021
Q3 | $1.37M | Sell |
30,900
-1,600
| -5% | -$70.9K | 0.04% | 276 |
|
|
2021
Q2 | $1.85M | Buy |
+32,500
| New | +$1.85M | 0.06% | 221 |
|
|
2018
Q2 | – | Sell |
-5,240
| Closed | -$845K | – | 770 |
|
|
2018
Q1 | $845K | Buy |
5,240
+100
| +2% | +$16.1K | 0.01% | 448 |
|
|
2017
Q4 | $846K | Buy |
+5,140
| New | +$846K | 0.01% | 439 |
|